The Centers for Disease Control and Prevention is looking for a company that can provide short proposals and quotations for the following requirement: (1) baculovirus stock and antigen production from four different recombinant protein baculovirus plasmids that will be provided by CDC, (2) purification of the antigen, and then (3) production of custom specific monoclonal antibodies (MAbs) that broadly reacts to epitopes of antigen which are conserved to all four constructs as well as MAbs that specifically binds to epitopes of antigen which are specific to each construct. This will be used to develop antigen-based assay that can be used as an ELISA-based format or rapid test.

The complete Statement of Work is attached.

This requirement will be awarded as a small purchase. Award will be made to the lowest bidder technically acceptable.

Please submit proposals before 12 p.m. (noon) on September 14, 2012, in the following manner:

- Attached via e-mail to [email protected] in a standard format, i.e. PDF or Word (.doc, .docx).
- Subject line should contain the solicitation number.
- Proposal narrative and quotation shall be submitted as separate documents.

Please address any questions about the Statement of Work to the purchasing agent.

This award is subject to availability of funds and may not be made this fiscal year. Due to the short time until the end of the fiscal year, the closing date cannot be extended.

Bid Protests Not Available